期刊
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
卷 2, 期 3, 页码 175-191出版社
ELSEVIER
DOI: 10.1016/S1572-1000(05)00097-9
关键词
Methylene blue; PDT; Photodynamic therapy; Apoptosis; Singlet oxygen; ROS; Cancer; Melanoma; Kaposi's sarcoma; Onychomicosis
类别
资金
- FAPESP
- CAPES
- CNPq
Methylene blue (MB) is a molecule that has been playing important roles in microbiology and pharmacology for some time. It has been widely used to stain living organisms, to treat methemoglobinemia, and lately it has been considered as a drug for photodynamic therapy (PDT). In this review, we start from the fundamental photophysical, photochemical and photobiological characteristics of this molecule and evolved to show in vitro and in vivo applications related to PDT. The clinical cases shown include treatments of basal cell carcinoma, Kaposi's Sarcoma, melanoma, virus and fungal infections. We concluded that used together with a recently developed continuous light source (RL50 (R)), MB has the potential to treat a variety of cancerous and non-cancerous diseases, with low toxicity and no side effects. (C) 2005 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据